APA

Borthwick A. D., Crame A. J., Ertl P. F., Exall A. M., Haley T. M., Hart G. J., Mason A. M., Pennell A. M. K., Singh O. M. P., Weingarten G. G. & Woolven J. M. (20020122). Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality. : Journal of medicinal chemistry.

Chicago

Borthwick Alan D, Crame Andrew J, Ertl Peter F, Exall Anne M, Haley Terry M, Hart Graham J, Mason Andrew M, Pennell Andrew M K, Singh Onkar M P, Weingarten Gordon G and Woolven James M. 20020122. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality. : Journal of medicinal chemistry.

Harvard

Borthwick A. D., Crame A. J., Ertl P. F., Exall A. M., Haley T. M., Hart G. J., Mason A. M., Pennell A. M. K., Singh O. M. P., Weingarten G. G. and Woolven J. M. (20020122). Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality. : Journal of medicinal chemistry.

MLA

Borthwick Alan D, Crame Andrew J, Ertl Peter F, Exall Anne M, Haley Terry M, Hart Graham J, Mason Andrew M, Pennell Andrew M K, Singh Onkar M P, Weingarten Gordon G and Woolven James M. Design and synthesis of pyrrolidine-5,5-trans-lactams (5-oxohexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 2. Potency and chirality. : Journal of medicinal chemistry. 20020122.